In , ProPublica analyzed payments by seven drug companies that had been required to make them public, finding recipients who had been disciplined, many for serious misconduct. Still, even drug and device makers that profess confidence in how they vet doctors today offer few details on what checks they run or whether they flagged the disciplinary cases ProPublica identified.
Device company Arthrex doesn't hire doctors who "do not possess the proper credentials and licensure for the task assigned," said spokeswoman Lisa Gardiner. She acknowledged, however, that the company checks the status of doctors only when their contracts begin, not annually as some companies do. While his contract obliged him to inform Arthrex if his licensure status changed, Gardiner said he never did.
The Pharmaceutical Research and Manufacturers of America, the industry trade group, wouldn't comment on the vetting processes of specific companies or whether there should be an industrywide standard for such checks.
Spokeswoman Holly Campbell said in an email that companies typically check lists of doctors barred from doing business with the government and confirm doctors' "general medical expertise, reputation and knowledge regarding a particular disease. Industry payments to doctors are legal as long as they are not an inducement to use a particular product.
Campbell defends the benefits of such financial ties, saying they compensate doctors for providing crucial feedback on products and help doctors teach their colleagues about what's out there. Critics of industry payments to doctors say they can influence recipients to prescribe drugs that cost more, may not be necessary or are similar to cheaper generics.
Charles Rosen, co-founder of the Association for Medical Ethics, which seeks to reduce manufacturers' influence on doctors, says he was not surprised to hear that disciplined doctors are among the industry's consultants and speakers. It's to sell a product," Rosen says.
Some companies that were making payments to disciplined doctors in appear to still do so, ProPublica found. When reached by phone, Reiss said that Janssen had performed a background check, but couldn't recall whether his disciplinary history had come up as part of his interview process. Reiss said he is retired from practice aside from his consulting work, but declined to say what this consists of or whether he does work for Janssen or any other company.
Janssen spokeswoman Meredith Sharp says the company's contracts require doctors to have active medical licenses, and that it conducts "additional reviews to verify eligibility" and requires doctors to disclose changes in status. In , the doctor's license was limited after he was found to have sexually harassed and inappropriately touched several female patients and staff members.
He was not allowed to see female patients without a chaperone for two years. Leon referred ProPublica to his attorney, who said he would speak to his client, but then did not return a call for comment. In a statement, AstraZeneca spokeswoman Abigail Bozarth said doctors with whom the company has financial relationships are reviewed both by an external organization and by the company's own compliance department.
Most recently, he turned his focus to electronic education, developing software applications to help patients navigate their conditions and treatments, as well as an image library of pediatric orthopedic disorders. Bow legs and knock knees. Developmental dysplasia of the hip DDH. Legg-Calve-Perthes disease. Spinal muscular atrophy SMA.
Spinal fusion surgery. Vertebral Body Tethering. Request appointment Refer a patient. About me Telehealth video visits. Also sees adult patients. J Bone Joint Surg Am. Idiopathic stroke after syndromic and neuromuscular scoliosis surgery: a case report and literature review. AME Case Rep. Schimke immunoosseous dysplasia and management considerations for vascular risks. Spine Deform. Rates and risk factors associated with unplanned hospital readmission after fusion for pediatric spinal deformity.
Spine J. Type of bone graft or substitute does not affect outcome of spine fusion with instrumentation for adolescent idiopathic scoliosis. Grey-scale ultrasound findings of lower extremity entheses in healthy children. Pediatr Rheumatol Online J.
Spinal fusion for scoliosis in patients with globally involved cerebral palsy: an ethical assessment. Culture and ethnicity influence outcomes of the Scoliosis Research Society Instrument in adolescent idiopathic scoliosis.
Use and outcomes of wound drain in spinal fusion for adolescent idiopathic scoliosis. Musculoskeletal disorders among spine surgeons: results of a survey of the Scoliosis Research Society membership. Fixation points within the main thoracic curve: does more instrumentation produce greater curve correction and improved results?
Patient satisfaction after surgical correction of adolescent idiopathic scoliosis. Prevalence and predictors of pain in surgical treatment of adolescent idiopathic scoliosis.
Use and outcome of MRI in the surgical treatment of adolescent idiopathic scoliosis. Patient self-assessment of appearance is improved more by all pedicle screw than by hybrid constructs in surgical treatment of adolescent idiopathic scoliosis. The minimum clinically important difference in Scoliosis Research Society Appearance, Activity, And Pain domains after surgical correction of adolescent idiopathic scoliosis. Transfusion-related acute lung injury after transfusion of maternal blood: a case-control study.
Preoperative and perioperative factors effect on adolescent idiopathic scoliosis surgical outcomes. Preoperative bracing affects postoperative outcome of posterior spine fusion with instrumentation for adolescent idiopathic scoliosis. Right thoracic curves in presumed adolescent idiopathic scoliosis: which clinical and radiographic findings correlate with a preoperative abnormal magnetic resonance image?
0コメント